tiprankstipranks
Trending News
More News >
Evommune, Inc. (EVMN)
NYSE:EVMN
US Market

Evommune, Inc. (EVMN) Income Statement

Compare
92 Followers

Evommune, Inc. Income Statement

Last quarter (Q4 2025), Evommune, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Evommune, Inc.'s net income was $-28.27M. See Evommune, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23
Total Revenue
$ 13.00M$ 7.00M$ 5.00M
Gross Profit
$ 11.61M$ 5.71M$ 4.00M
Operating Expenses
$ 92.68M$ 75.73M$ 41.85M
Depreciation and Amortization
$ 1.39M$ 1.29M$ 1.00M
EBITDA
$ -79.68M$ -65.49M$ -32.99M
Operating Income
$ -81.07M$ -70.01M$ -37.85M
Other Income/Expenses
$ 12.20M$ 3.20M$ 3.80M
Pretax Income
$ -68.87M$ -66.81M$ -34.05M
Net Income
$ -68.87M$ -66.81M$ -34.05M
Per Share Metrics
Basic EPS
$ -2.18$ -2.27$ -1.13
Diluted EPS
$ -2.18$ -2.27$ -1.13
Weighted Average Shares Outstanding
31.52M 30.08M 30.08M
Weighted Average Shares Outstanding (Diluted)
31.52M 30.08M 30.08M
Currency in USD

Evommune, Inc. Earnings and Revenue History